279 related articles for article (PubMed ID: 6158263)
1. Antiarrhythmic efficacy, pharmacokinetics and safety of N-acetylprocainamide in human subjects: comparison with procainamide.
Roden DM; Reele SB; Higgins SB; Wilkinson GR; Smith RF; Oates JA; Woosley RL
Am J Cardiol; 1980 Sep; 46(3):463-8. PubMed ID: 6158263
[TBL] [Abstract][Full Text] [Related]
2. Clinical pharmacology and antiarrhythmic efficacy of N-acetylprocainamide.
Winkle RA; Jaillon P; Kates RE; Peters F
Am J Cardiol; 1981 Jan; 47(1):123-30. PubMed ID: 6161534
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of N-acetylprocainamide in long-term treatment of ventricular arrhythmias.
Atkinson AJ; Lertora JJ; Kushner W; Chao GC; Nevin MJ
Clin Pharmacol Ther; 1983 May; 33(5):565-76. PubMed ID: 6188570
[TBL] [Abstract][Full Text] [Related]
4. The clinical pharmacology and antiarrhythmic efficacy of acetylprocainamide in patients with arrhythmias.
Kluger J; Drayer D; Reidenberg M; Ellis G; Lloyd V; Tyberg T; Hayes J
Am J Cardiol; 1980 Jun; 45(6):1250-7. PubMed ID: 6155064
[TBL] [Abstract][Full Text] [Related]
5. Clinical pharmacokinetics of N-acetylprocainamide.
Connolly SJ; Kates RE
Clin Pharmacokinet; 1982; 7(3):206-20. PubMed ID: 6178545
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic interaction of N-acetyl procainamide and procainamide in humans.
Funck-Brentano C; Light RT; Lineberry MD; Wright GM; Roden DM; Woosley RL
J Cardiovasc Pharmacol; 1989 Sep; 14(3):364-73. PubMed ID: 2476614
[TBL] [Abstract][Full Text] [Related]
7. N-Acetylprocainamide kinetics and clinical response during repeated dosing.
Rodman JH; Hurst A; Gaarder T; Cohen J; Jelliffe RW
Clin Pharmacol Ther; 1982 Sep; 32(3):378-86. PubMed ID: 6179685
[TBL] [Abstract][Full Text] [Related]
8. Torsade de pointes induced by N-acetylprocainamide.
Chow MJ; Piergies AA; Bowsher DJ; Murphy JJ; Kushner W; Ruo TI; Asada A; Talano JV; Atkinson AJ
J Am Coll Cardiol; 1984 Sep; 4(3):621-4. PubMed ID: 6206104
[TBL] [Abstract][Full Text] [Related]
9. Procainamide: clinical pharmacology and efficacy against ventricular arrhythmias.
Giardina EG
Ann N Y Acad Sci; 1984; 432():177-88. PubMed ID: 6084435
[TBL] [Abstract][Full Text] [Related]
10. Acecainide (N-acetylprocainamide). A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in cardiac arrhythmias.
Harron DW; Brogden RN
Drugs; 1990 May; 39(5):720-40. PubMed ID: 1693889
[TBL] [Abstract][Full Text] [Related]
11. Effect kinetics of N-acetylprocainamide-induced QT interval prolongation.
Piergies AA; Ruo TI; Jansyn EM; Belknap SM; Atkinson AJ
Clin Pharmacol Ther; 1987 Jul; 42(1):107-12. PubMed ID: 2439251
[TBL] [Abstract][Full Text] [Related]
12. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease.
Wynn J; Miura DS; Torres V; Flowers D; Keefe D; Williams S; Somberg JC
Am J Cardiol; 1985 Nov; 56(13):877-81. PubMed ID: 2414983
[TBL] [Abstract][Full Text] [Related]
13. Theoretical basis for interest in acetylprocainamide and clinical experiences with this new antiarrhythmic agent.
Drayer D; Kluger J; Reidenberg M; Lahita R
Drug Metab Rev; 1979; 10(2):239-46. PubMed ID: 95247
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of N-acetylprocainamide.
Atkinson AJ; Ruo TI
Angiology; 1986 Dec; 37(12 Pt 2):959-67. PubMed ID: 2433970
[TBL] [Abstract][Full Text] [Related]
15. Use of procainamide in chronic ambulatory peritoneal dialysis: report of a case.
Kroboth PD; Mitchum K; Puschett JB
Am J Kidney Dis; 1984 Jul; 4(1):78-9. PubMed ID: 6204527
[TBL] [Abstract][Full Text] [Related]
16. Acetylprocainamide therapy in patients with previous procainamide-induced lupus syndrome.
Kluger J; Drayer DE; Reidenberg MM; Lahita R
Ann Intern Med; 1981 Jul; 95(1):18-23. PubMed ID: 6166229
[TBL] [Abstract][Full Text] [Related]
17. Long-term antiarrhythmic therapy with acetylprocainamide.
Kluger J; Leech S; Reidenberg MM; Lloyd V; Drayer DE
Am J Cardiol; 1981 Dec; 48(6):1124-32. PubMed ID: 6171156
[TBL] [Abstract][Full Text] [Related]
18. Procainamide, N-acetylprocainamide, antinuclear antibody and systemic lupus erythematosus.
Reidenberg MM; Drayer DE
Angiology; 1986 Dec; 37(12 Pt 2):968-71. PubMed ID: 2433971
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic studies of procainamide (PA) and N-acetylprocainamide (NAPA) in healthy subjects.
Wierzchowiecki M; Michałowska D; Lowicki Z; Ochotny R; Grześkowiak A; Tomaszkiewicz T
Int J Clin Pharmacol Ther Toxicol; 1980 Jun; 18(6):272-6. PubMed ID: 6161089
[TBL] [Abstract][Full Text] [Related]
20. N-acetylprocainamide's antiarrhythmic action in patients with ventricular tachycardia.
Somberg J; Wynn J; Miura D; Torres V; Williams S; Keefe D
Angiology; 1986 Dec; 37(12 Pt 2):972-81. PubMed ID: 2433972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
